Author
Listed:
- Alex S. Hartlage
(The Research Institute at Nationwide Children’s Hospital
The Ohio State University)
- Satyapramod Murthy
(The Research Institute at Nationwide Children’s Hospital)
- Arvind Kumar
(The Research Institute at Nationwide Children’s Hospital)
- Sheetal Trivedi
(The Research Institute at Nationwide Children’s Hospital)
- Piyush Dravid
(The Research Institute at Nationwide Children’s Hospital)
- Himanshu Sharma
(The Research Institute at Nationwide Children’s Hospital)
- Christopher M. Walker
(The Research Institute at Nationwide Children’s Hospital
The Ohio State University)
- Amit Kapoor
(The Research Institute at Nationwide Children’s Hospital
The Ohio State University)
Abstract
Efforts to develop an effective vaccine against the hepatitis C virus (HCV; human hepacivirus) have been stymied by a lack of small animal models. Here, we describe an experimental rat model of chronic HCV-related hepacivirus infection and its response to T cell immunization. Immune-competent rats challenged with a rodent hepacivirus (RHV) develop chronic viremia characterized by expansion of non-functional CD8+ T cells. Single-dose vaccination with a recombinant adenovirus vector expressing hepacivirus non-structural proteins induces effective immunity in majority of rats. Resolution of infection coincides with a vigorous recall of intrahepatic cellular responses. Host selection of viral CD8 escape variants can subvert vaccine-conferred immunity. Transient depletion of CD8+ cells from vaccinated rats prolongs infection, while CD4+ cell depletion results in chronic viremia. These results provide direct evidence that co-operation between CD4+ and CD8+ T cells is important for hepacivirus immunity, and that subversion of responses can be prevented by prophylactic vaccination.
Suggested Citation
Alex S. Hartlage & Satyapramod Murthy & Arvind Kumar & Sheetal Trivedi & Piyush Dravid & Himanshu Sharma & Christopher M. Walker & Amit Kapoor, 2019.
"Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection,"
Nature Communications, Nature, vol. 10(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09105-0
DOI: 10.1038/s41467-019-09105-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09105-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.